Clinical Trial Update: Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Trafermin (fibroblast growth factor-2) for periodontal tissue regeneration has completed its study in periodontitis with ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Trafermin (fibroblast growth factor-2 (FGF-2))

Snippet

Sponsor: Kaken Pharmaceutical | Conditions: Periodontitis, Alveolar Bone Loss | Phase 3 | Status: COMPLETED